Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

被引:32
作者
Goh, B. K. P.
Chow, P. K. H.
Chuah, K. L.
Yap, W. M.
Wong, W. K.
机构
[1] Singapore Gen Hosp, Dept Surg, Singapore 169608, Singapore
[2] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
来源
EJSO | 2006年 / 32卷 / 09期
关键词
gastrointestinal stromal tumor; GIST; neoadjuvant; imatinib; Gleevec; response;
D O I
10.1016/j.ejso.2006.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of this study is to review the radiologic, PET scan and pathologic response and the outcome of patients with advanced GIST treated with neoadjuvant IM followed by surgical resection. Materials and methods: We report a case and review 36 patients reported in MEDLINE with advanced GIST treated with neoadjuvant IM followed by surgical resection. Results: Thirty-seven patients with a median age of 56 years (range, 32-76 years) at presentation were treated with neoadjuvant IM. Radiologic response accurately predicted pathological response in 31/36 patients, whereas PET scan was accurate in predicting treatment response in only 6/23 patients. Conclusion: This study demonstrates that the pathologic response of GIST to IM is usually incomplete and does not correlate with the complete response seen on PET scan. This finding suggests that surgical resection will continue to play a vital role in the treatment of patients with advanced disease responding to IM treatment. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:961 / 963
页数:3
相关论文
共 21 条
[1]   Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib [J].
Bauer, S ;
Hartmann, JT ;
de Wit, M ;
Lang, H ;
Grabellus, F ;
Antoch, G ;
Niebel, W ;
Erhard, J ;
Ebeling, P ;
Zeth, M ;
Taeger, G ;
Seeber, S ;
Flasshove, M ;
Schütte, J .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) :316-325
[2]   Complete remission with imatinib in metastastic gastrointestinal stromal tumors [J].
Bauer, S ;
Lang, H ;
Schütte, J ;
Hartmann, JT .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6800-6801
[3]  
Blanke CD, 2001, P AN M AM SOC CLIN, V20, P2
[4]   Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib:: a centre-based study of 17 patients [J].
Bümming, P ;
Andersson, J ;
Meis-Kindblom, JM ;
Klingenstierna, H ;
Engström, K ;
Stierner, U ;
Wängberg, B ;
Jansson, S ;
Ahlman, H ;
Kindblom, LG ;
Nilsson, B .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :460-464
[5]   Case 3.: Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate [J].
Chacón, M ;
Roca, E ;
Huertas, E ;
Loria, FS ;
Domenechini, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1580-1582
[6]   Gastrointestinal stromal tumours [J].
Connolly, EM ;
Gaffney, E ;
Reynolds, JV .
BRITISH JOURNAL OF SURGERY, 2003, 90 (10) :1178-1186
[7]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[8]   Clinical management of gastrointestinal stromal tumors: Before and after STI-571 [J].
DeMatteo, RP ;
Heinrich, MC ;
El-Rifai, WM ;
Demetri, G .
HUMAN PATHOLOGY, 2002, 33 (05) :466-477
[9]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[10]   Surgery and imatinib in the management of GIST: Emerging approaches to adjuvant and neoadjuvant therapy [J].
Eisenberg, BL ;
Judson, I .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (05) :465-475